
Trump’s 100% tariffs on branded drugs: Indian generics spared but pose risks for pharma sector – Explained
US President Donald Trump‘s announcement of a 100% tariff on imported “branded and patented pharmaceutical products” has rattled the global pharma industry, though Indian generic drug makers are largely expected to remain unaffected for now.Trump, in a post on Truth Social on Thursday, stated: “Starting October 1st, 2025, we will be imposing a 100% Tariff…